North America Hemp-derived Cannabidiol Market Size, Share & Trends Analysis Report By Product Type (Hemp-derived CBD Isolate, Hemp-derived CBD Distillate, Hemp-derived CBD Terpenes), By End-use, And Segment Forecasts, 2020 - 2027

Published: Nov, 2020 | Pages: 82 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

"North America Hemp-derived CBD Market Growth & Trends

The North America hemp-derived cannabidiol market size is expected to reach USD 16.1 billion by 2027. It is expected to expand at a compound annual growth rate (CAGR) of 27.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing awareness and adoption of cannabidiol (CBD) for various health conditions are the key factors driving the growth of this market. The liberalization of laws related to hemp cultivation by North America countries is further increasing its adoption.

Based on product type, hemp-derived CBD distillate dominated the market with a share of 58.5% in 2019. The large share is attributed to factors such as high consumption of cannabidiol distillate in various applications due to its wellness and therapeutic uses. Also, encouraging government reforms regarding its utilization is increasing the adoption of these products. Furthermore, the hemp-derived CBD terpenes segment is expected to grow at the fastest CAGR over the forecast period. Rising awareness and additional health benefits provided by terpenes are expected to propel the demand for cannabidiol terpenes over the forecast period.

In 2019, based on end-use, personal care, and cosmetics accounted for the highest revenue share owing to the growing application of hemp-derived cannabidiol in personal care and cosmetic products. On the other hand, the food and beverage segment is expected to grow at the highest CAGR over the forecast period. The legalization of cannabidiol-infused edibles, coupled with increasing awareness regarding the health benefits of CBD, is one of the major factors driving the growth of this segment.

The U.S. dominated the North America market, with a revenue share of 82.4% in 2019. Increasing awareness about cannabidiol benefits, growing consumer preference towards such products, supportive government reforms, and favorable climatic conditions are some of the key factors fueling the market growth. Mexico is expected to exhibit a lucrative CAGR over the forecast period owing to rising awareness regarding CBD based products and their utilization.

North America Hemp-derived CBD Market Report Highlights

• The is anticipated to be valued at USD 16.1 billion by 2027, owing to growing awareness and adoption of cannabidiol for various health conditions

• The hemp-derived CBD distillate segment dominated the market in 2019, owing to the high product consumption for wellness and medicinal purposes

• The personal care and cosmetics segment dominated the market in 2019, owing to the growing application of hemp-derived CBD in various personal care and cosmetic products

• The U.S. dominated the market with a revenue share of 82.4% in 2019, owing to increasing awareness about hemp-derived cannabidiol benefits and growing consumer preference for such products"

 "Table of Contents

Chapter 1 Methodology and Scope
                  1.1 Research Methodology
                      1.1.1 Information Procurement
                  1.2 Information or Data Analysis
                  1.3 Market Formulation & Validation
                      1.3.1 Region Market: CAGR Calculation
                  1.4 Region-Based Segment Share Calculation
                  1.5 List of Secondary Sources
                  1.6 List of Primary Sources
Chapter 2 Executive Summary
                  2.1 Market Summary, Revenue (USD Million)
Chapter 3 North America Hemp-derived Cannabidiol (CBD) Market Variables, Trends & Scope
                  3.1 Market Segmentation
                  3.2 Penetration & Growth Prospects Mapping
                  3.3 Market Dynamics
                      3.3.1 Market Driver Analysis
                          3.3.1.1 Growing legalization of CBD products
                          3.3.1.2 Increasing use of CBD-infused products in personal care & cosmetics, along with other products
                      3.3.2 Market Restraint Analysis
                          3.3.2.1 High cost of CBD products
                      3.3.3 Opportunity Analysis (2019-2027)
                  3.4 North America Hemp-derived Cannabidiol (CBD) Market Analysis Tools
                      3.4.1 North America Hemp-Derived Cannabidiol (CBD) - Porter’s Analysis
                      3.4.2 North America Hemp-Derived Cannabidiol (CBD) - PESTEL Analysis
                  3.5 Regulatory Scenario, by Country
                      3.5.1 U.S.
                          3.5.1.1 Regulatory Bodies Involved
                          3.5.1.2 Import/Export Scenario
                      3.5.2 CANADA
                          3.5.2.1 Regulatory Bodies Involved
                          3.5.2.2 Import/Export Scenario
                      3.5.3 MEXICO
                          3.5.3.1 Regulatory Bodies Involved
                          3.5.3.2 Import/Export Scenario
                  3.6 Bulk CBD Pricing Analysis, by Country, 2019 & future trends
                  3.7 Product Adoption Pattern Analysis, by End Use
                      3.7.1 Personal Care and Cosmetics
                      3.7.2 Food and Beverages
                      3.7.3 Nutraceuticals
                      3.7.4 Others
Chapter 4 Competitive Analysis
                  4.1 Company Position Analysis
                  4.2 List of Companies producing Hemp-derived CBD Products
                  4.3 List of Companies purchasing Hemp-derived CBD Products
Chapter 5 North America Hemp-derived Cannabidiol (CBD) Market: Product Type Estimates & Trend Analysis
                  5.1 Segment Dashboard
                  5.2 North America Hemp-derived Cannabidiol (CBD) Market, By Product Type Analysis
                  5.3 Hemp-derived CBD Distillate
                      5.3.1 Hemp-derived CBD Distillate Market Estimates and Forecasts, 2016 - 2027 (USD Million)
                  5.4 Hemp-derived CBD Isolate
                      5.4.1 Hemp-derived CBD Isolate Market Estimates And Forecasts, 2016 - 2027 (USD Million)
                  5.5 Hemp-derived CBD Terpenes
                      5.5.1 Hemp-derived CBD Terpenes Market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 6 North America Hemp-derived Cannabidiol (CBD) Market: End-Use Estimates & Trend Analysis
                  6.1 Segment Dashboard
                  6.2 North America Hemp-derived Cannabidiol (CBD) Market, By End-use Analysis
                  6.3 Personal Care and Cosmetics
                      6.3.1 Personal Care and Cosmetics Use Market Estimates and Forecasts, 2016 - 2027 (USD Million)
                  6.4 Food & Beverages
                      6.4.1 Food & Beverages Market Estimates and Forecasts, 2016 - 2027 (USD Million)
                  6.5 Nutraceuticals
                      6.5.1 Nutraceuticals Market Estimates and Forecasts, 2016 - 2027 (USD Million)
                  6.6 Others
                      6.6.1 Others Market Estimates and Forecasts, 2016- 2027 (USD Million)
Chapter 7 North America Hemp-derived Cannabidiol (CBD) Market: Regional Estimates & Trend Analysis
                  7.1 North America Hemp-derived Cannabidiol Market Share, By Region, 2019 & 2027
                  7.2 North America
                      7.2.1 north America Hemp-derived CBD market estimates and forecasts, 2016 - 2027 (USD Million)
                      7.2.2 U.S.
                          7.2.2.1 U.S. Hemp-derived cannabidiol market estimates and forecasts, 2016 - 2027 (USD Million)
                      7.2.3 CANADA
                          7.2.3.1 Canada Hemp-derived CBD market estimates and forecasts, 2016 - 2027 (USD Million)
                      7.2.4 MEXICO
                          7.2.4.1 Mexico Hemp-derived CBD market estimates and forecasts, 2016 - 2027 (USD Million)
Chapter 8 Competitive Landscape
                  8.1 Company Profiles
                      8.1.1 ELIXINOL
                          8.1.1.1 Company Overview
                          8.1.1.2 Financial Performance
                          8.1.1.3 Product Benchmarking
                          8.1.1.4 Strategic Initiatives
                      8.1.2 ENDOCA
                          8.1.2.1 Company Overview
                          8.1.2.2 Product Benchmarking
                          8.1.2.3 Strategic Initiatives
                      8.1.3 HEMPMEDS
                          8.1.3.1 Company Overview
                          8.1.3.2 Product Benchmarking
                          8.1.3.3 Strategic Initiatives
                      8.1.4 KAZMIRA
                          8.1.4.1 Company Overview
                          8.1.4.2 Product Benchmarking
                          8.1.4.3 Strategic Initiatives
                      8.1.5 CV SCIENCES, INC.
                          8.1.5.1 Company Overview
                          8.1.5.2 Product Benchmarking
                          8.1.5.3 Strategic Initiatives
                      8.1.6 ISODIOL
                          8.1.6.1 Company Overview
                          8.1.6.2 Financial Performance
                          8.1.6.3 Product Benchmarking
                          8.1.6.4 Strategic Initiatives
                      8.1.7 CBD LIFE
                          8.1.7.1 Company Overview
                          8.1.7.2 Product Benchmarking
                          8.1.7.3 Strategic Initiatives
                      8.1.8 CBD AMERICAN SHAMAN.
                          8.1.8.1 Company Overview
                          8.1.8.2 Product Benchmarking
                      8.1.9 IRIECBD
                          8.1.9.1 Company Overview
                          8.1.9.2 Product Benchmarking
                          8.1.9.3 Strategic Initiatives
                      8.1.10 BLUEBIRD BOTANICALS
                          8.1.10.1 Company Overview
                          8.1.10.2 Product Benchmarking
                          8.1.10.3 Strategic Initiatives
                      8.1.11 TRUE BLUE
                          8.1.11.1 Company Overview
                          8.1.11.2 Product Benchmarking
                      8.1.12 GROFF NORTH AMERICA HEMPLEX
                          8.1.12.1 Company Overview
                          8.1.12.2 Product Benchmarking"

"List of Tables

Table 1 List of secondary sources
Table 2 List of primary sources
Table 3 Average bulk price of CBD per gram, by country, 2019 - 2027 (USD)
Table 4 North America hemp-derived CBD market, by Product, 2016 - 2027 (USD Million)
Table 5 North America hemp-derived CBD market, by End use, 2016 - 2027 (USD Million)
Table 6 U.S. hemp-derived CBD market, by Product, 2016 - 2027 (USD Million)
Table 7 U.S. hemp-derived CBD market, by End use, 2016 - 2027 (USD Million)
Table 8 Canada hemp-derived CBD market, by Product, 2016 - 2027 (USD Million)
Table 9 Canada hemp-derived CBD market, by End use, 2016 - 2027 (USD Million)
Table 10 Mexico hemp-derived CBD market, by Product, 2016 - 2027 (USD Million)
Table 11 Mexico hemp-derived CBD market, by End use, 2016 - 2027 (USD Million)
"	"List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 North America hemp-derived Cannabidiol (CBD) market snapshot, 2019 (USD Million)
Fig. 9 North America Hemp-derived Cannabidiol (CBD) market segmentation
Fig. 10 Penetration & growth prospects mapping for North America hemp-derived cannabidiol market
Fig. 11 North America hemp-derived cannabidiol market driver impact
Fig. 12 North America hemp-derived cannabidiol market restraints impact
Fig. 13 Opportunity analysis (USD Billion)
Fig. 14 North America hemp-derived Cannabidiol (CBD) - Porter’s Analysis
Fig. 15 North America hemp-derived Cannabidiol (CBD) -PESTEL Analysis
Fig. 16 Company market position analysis
Fig. 17 North America hemp-derived cannabidiol market, product outlook: Key takeaways
Fig. 18 North America hemp-derived Cannabidiol (CBD) market by product, 2019 & 2027 (USD Million)
Fig. 19 Hemp-derived CBD distillate market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 20 Hemp-derived CBD isolate market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 21 Hemp-derived CBD terpenes market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 22 North America hemp Cannabidiol (CBD) market, end-use outlook: Key takeaways
Fig. 23 North America hemp-derived Cannabidiol (CBD) market by end-use, 2019 & 2027 (USD Million)
Fig. 24 Personal care and cosmetics market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 25 Food & beverages market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 26 Nutraceuticals market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 27 Others market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 North America hemp-derived cannabidiol market: Regional outlook, 2019 & 2027
Fig. 30 North America hemp-derived CBD market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 31 U.S. hemp-derived CBD market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 32 Canada hemp-derived CBD market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 33 Mexico hemp-derived CBD market estimates and forecasts, 2016 - 2027 (USD Million)"